Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Compound K improves skin barrier function by increasing SPINK5 expression

  • Park, No-June (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Bong, Sim-Kyu (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Lee, Sullim (Department of Life Science, College of Bio-Nano Technology, Gachon University) ;
  • Jung, Yujung (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Jegal, Hyun (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Kim, Jinchul (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Kim, Si-Kwan (Department of Biomedical Chemistry, College of Biomedical & Health Science, Konkuk University) ;
  • Kim, Yong Kee (College of Pharmacy, Sookmyung Women's University) ;
  • Kim, Su-Nam (Natural Products Research Institute, Korea Institute of Science and Technology)
  • Received : 2019.05.13
  • Accepted : 2019.11.07
  • Published : 2020.11.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The skin acts as a barrier to protect organisms against harmful exogenous agents. Compound K (CK) is an active metabolite of ginsenoside Rb1, Rb2 and Rc, and researchers have focused on its skin protective efficacy. In this study, we hypothesized that increased expression of the serine protease inhibitor Kazal type-5 (SPINK5) may improve skin barrier function. Methods: We screened several ginsenosides to increase SPINK5 gene promoter activity using a transactivation assay and found that CK can increase SPINK5 expression. To investigate the protective effect of CK on the skin barrier, RT-PCR and Western blotting were performed to investigate the expression levels of SPINK5, kallikrein 5 (KLK5), KLK7 and PAR2 in UVB-irradiated HaCaT cells. Measurement of transepidermal water loss (TEWL) and histological changes associated with the skin barrier were performed in a UVB-irradiated mouse model and a 1-chloro-2,4-dinitrobenzene (DNCB)-induced atopic dermatitis-like model. Results: CK treatment increased the expression of SPINK5 and decreased the expression of its downstream genes, such as KLKs and PAR2. In the UVB-irradiated mouse model and the DNCB-induced atopic dermatitis model, CK restored increased TEWL and decreased hydration and epidermal hyperplasia. In addition, CK normalized the reduced SPINK5 expression caused by UVB or DNCB, thereby restoring the expression of the proteins involved in desquamation to a level similar to normal. Conclusions: Our data showed that CK contributes to improving skin-barrier function in UVB-irradiated and DNCB-induced atopic dermatitis-like models through SPINK5. These results suggest that therapeutic attempts with CK might be useful in treating barrier-disrupted diseases.

Keywords

References

  1. Antonov D, Schliemann S, Elsner P. Methods for the assessment of barrier function. Curr Probl Dermatol 2016;49:61-70. https://doi.org/10.1159/000441546
  2. North AJ, Bardsley WG, Hyam J, Bornslaeger EA, Cordingley HC, Trinnaman B, Hatzfeld M, Green KJ, Magee AI, Garrod DR. Molecular map of the desmosomal plaque. J Cell Sci 1999;112:4325-36. https://doi.org/10.1242/jcs.112.23.4325
  3. Angst BD, Marcozzi C, Magee AI. The cadherin superfamily: diversity in form and function. J Cell Sci 2001;114:629-41. https://doi.org/10.1242/jcs.114.4.629
  4. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 2001;22:184-204. https://doi.org/10.1210/er.22.2.184
  5. Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, Takehara K, Saijoh K. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J Invest Dermatol 2003;121:542-9. https://doi.org/10.1046/j.1523-1747.2003.12363.x
  6. Komatsu N, Saijoh K, Toyama T, Ohka R, Otsuki N, Hussack G, Takehara K, Diamandis EP. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br J Dermatol 2005;153:274-81. https://doi.org/10.1111/j.1365-2133.2005.06754.x
  7. Pierard GE, Goffin V, Hermanns-Le T, Pierard-Franchimont C. Corneocyte desquamation. Int J Mol Med 2000;6:217-21. https://doi.org/10.1007/PL00010728
  8. Ya-Xian Z, Suetake T, Tagami H. Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res 1999;291:555-9. https://doi.org/10.1007/s004030050453
  9. Harding K. Challenges for skin and wound care in the new century. Adv Skin Wound Care 2000;13(212):215.
  10. Raghunath M, Tontsidou L, Oji V, Aufenvenne K, Schurmeyer-Horst F, Jayakumar A, Stander H, Smolle J, Clayman GL, Traupe H. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol 2004;123:474-83. https://doi.org/10.1111/j.0022-202X.2004.23220.x
  11. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafe JL, Wilkinson J, Taieb A, Barrandon Y, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000;25:141-2. https://doi.org/10.1038/75977
  12. Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K, Saijoh K. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 2002;118:436-43. https://doi.org/10.1046/j.0022-202x.2001.01663.x
  13. Komatsu N, Saijoh K, Jayakumar A, Clayman GL, Tohyama M, Suga Y, Mizuno Y, Tsukamoto K, Taniuchi K, Takehara K, et al. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. J Invest Dermatol 2008;128:1148-59. https://doi.org/10.1038/sj.jid.5701153
  14. Stoll C, Alembik Y, Tchomakov D, Messer J, Heid E, Boehm N, Calvas P, Hovnanian A. Severe hypernatremic dehydration in an infant with Netherton syndrome. Genet Couns 2001;12:237-43.
  15. Nin M, Katoh N, Kokura S, Handa O, Yoshikawa T, Kishimoto S. Dichotomous effect of ultraviolet B on the expression of corneodesmosomal enzymes in human epidermal keratinocytes. J Dermatol Sci 2009;54:17-24. https://doi.org/10.1016/j.jdermsci.2008.11.004
  16. Nishio Y, Noguchi E, Shibasaki M, Kamioka M, Ichikawa E, Ichikawa K, Umebayashi Y, Otsuka F, Arinami T. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 2003;4:515-7. https://doi.org/10.1038/sj.gene.6363889
  17. Zhao LP, Di Z, Zhang L, Wang L, Ma L, Lv Y, Hong Y, Wei H, Chen HD, Gao XH. Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China. J Eur Acad Dermatol Venereol 2012;26:572-7. https://doi.org/10.1111/j.1468-3083.2011.04120.x
  18. Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, Wong K, Abecasis GR, Jones EY, Harper JI, et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29:175-8. https://doi.org/10.1038/ng728
  19. Kim E, Kim D, Yoo S, Hong YH, Han SY, Jeong S, Jeong D, Kim JH, Cho JY, Park J. The skin protective effects of compound K, a metabolite of ginsenoside Rb1 from Panax ginseng. J Ginseng Res 2018;42:218-24. https://doi.org/10.1016/j.jgr.2017.03.007
  20. Kim JR, Choi J, Kim J, Kim H, Kang H, Kim EH, Chang JH, Kim YE, Choi YJ, Lee KW, et al. 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol-fortified ginseng extract attenuates the development of atopic dermatitis-like symptoms in NC/Nga mice. J Ethnopharmacol 2014;151:365-71. https://doi.org/10.1016/j.jep.2013.10.058
  21. Corcuff P, Leveque JL. Corneocyte changes after acute UV irradiation and chronic solar exposure. Photodermatol 1988;5:110-5.
  22. Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009;206:1135-47. https://doi.org/10.1084/jem.20082242
  23. Le NA, Katsuyama M, Demura M, Tanii H, Katsuyama H, Saijoh K. Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes. Environ Health Prev Med 2014;19:307-13. https://doi.org/10.1007/s12199-014-0393-7
  24. Denda M, Sokabe T, Fukumi-Tominaga T, Tominaga M. Effects of skin surface temperature on epidermal permeability barrier homeostasis. J Invest Dermatol 2007;127:654-9. https://doi.org/10.1038/sj.jid.5700590
  25. Huang KF, Ma KH, Liu PS, Chen BW, Chueh SH. Ultraviolet B irradiation increases keratin 1 and keratin 10 expressions in HaCaT keratinocytes via TRPV1 activation and ERK phosphorylation. Exp Dermatol 2017;26:832-5. https://doi.org/10.1111/exd.13292
  26. Inagaki N, Nagai H. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:mouse models for the development of remedies for human allergic dermatitis. J Pharmacol Sci 2009;110:251-9. https://doi.org/10.1254/jphs.09R01FM
  27. Lee JW, Wu Q, Jang YP, Choung SY. Pinus densiflora bark extract ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice by regulating Th1/Th2 balance and skin barrier function. Phytother Res 2018;32:1135-43. https://doi.org/10.1002/ptr.6061

Cited by

  1. The Complex Interplay between Autophagy and NLRP3 Inflammasome in Renal Diseases vol.22, pp.23, 2021, https://doi.org/10.3390/ijms222312766
  2. Protective effect of oligosaccharides isolated from Panax ginseng C. A. Meyer against UVB-induced skin barrier damage in BALB/c hairless mice and human keratinocytes vol.283, 2020, https://doi.org/10.1016/j.jep.2021.114677